Annual Total Long Term Liabilities
$1.44 M
-$146.00 K-9.19%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual total long term liabilities is $1.44 million, with the most recent change of -$146.00 thousand (-9.19%) on December 1, 2023.
- During the last 3 years, NBY annual total long term liabilities has risen by +$1.35 million (+1557.47%).
- NBY annual total long term liabilities is now -86.09% below its all-time high of $10.37 million, reached on December 31, 2021.
Performance
NBY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$821.00 K
-$111.00 K-11.91%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly total long term liabilities is $821.00 thousand, with the most recent change of -$111.00 thousand (-11.91%) on September 1, 2024.
- Over the past year, NBY quarterly long term liabilities has dropped by -$423.00 thousand (-34.00%).
- NBY quarterly long term liabilities is now -92.08% below its all-time high of $10.37 million, reached on December 31, 2021.
Performance
NBY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
NBY Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.2% | -34.0% |
| 3 y3 years | +1557.5% | -40.5% |
| 5 y5 years | +157.5% | -40.5% |
NBY Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.1% | at low | -92.1% | at low |
| 5 y | 5-year | -86.1% | +1557.5% | -92.1% | >+9999.0% |
| alltime | all time | -86.1% | +1557.5% | -92.1% | -100.0% |
NovaBay Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $821.00 K(-11.9%) |
| Jun 2024 | - | $932.00 K(-26.8%) |
| Mar 2024 | - | $1.27 M(-11.7%) |
| Dec 2023 | $1.44 M(-9.2%) | $1.44 M(+15.9%) |
| Sep 2023 | - | $1.24 M(-9.8%) |
| Jun 2023 | - | $1.38 M(-8.8%) |
| Mar 2023 | - | $1.51 M(-4.8%) |
| Dec 2022 | $1.59 M(-84.7%) | $1.59 M(-67.5%) |
| Sep 2022 | - | $4.88 M(+127.9%) |
| Jun 2022 | - | $2.14 M(-5.4%) |
| Mar 2022 | - | $2.26 M(-78.2%) |
| Dec 2021 | $10.37 M(>+9900.0%) | $10.37 M(>+9900.0%) |
| Sep 2021 | - | $1000.00(-80.0%) |
| Jun 2021 | - | $5000.00(-44.4%) |
| Mar 2021 | - | $9000.00(-89.7%) |
| Dec 2020 | $87.00 K(-98.1%) | $87.00 K(-55.8%) |
| Sep 2020 | - | $197.00 K(-97.5%) |
| Jun 2020 | - | $7.99 M(+84.0%) |
| Mar 2020 | - | $4.34 M(-4.8%) |
| Dec 2019 | $4.56 M(+714.3%) | $4.56 M(-16.0%) |
| Sep 2019 | - | $5.43 M(+11.9%) |
| Jun 2019 | - | $4.85 M(+52.6%) |
| Mar 2019 | - | $3.18 M(+467.3%) |
| Dec 2018 | $560.00 K(-77.7%) | $560.00 K(-39.7%) |
| Sep 2018 | - | $929.00 K(-23.9%) |
| Jun 2018 | - | $1.22 M(-29.6%) |
| Mar 2018 | - | $1.73 M(-30.8%) |
| Dec 2017 | $2.51 M(-36.7%) | $2.51 M(-36.7%) |
| Sep 2017 | - | $3.96 M(-4.0%) |
| Jun 2017 | - | $4.13 M(+2.5%) |
| Mar 2017 | - | $4.02 M(+1.7%) |
| Dec 2016 | $3.96 M(-28.6%) | $3.96 M(-15.7%) |
| Sep 2016 | - | $4.70 M(-8.0%) |
| Jun 2016 | - | $5.10 M(-37.8%) |
| Mar 2016 | - | $8.20 M(+48.0%) |
| Dec 2015 | $5.54 M | $5.54 M(+150.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $2.21 M(-12.0%) |
| Jun 2015 | - | $2.51 M(+8.7%) |
| Mar 2015 | - | $2.31 M(-1.5%) |
| Dec 2014 | $2.34 M(-33.2%) | $2.34 M(-21.9%) |
| Sep 2014 | - | $3.00 M(+31.8%) |
| Jun 2014 | - | $2.28 M(-25.8%) |
| Mar 2014 | - | $3.07 M(-12.5%) |
| Dec 2013 | $3.51 M(+74.2%) | $3.51 M(-6.8%) |
| Sep 2013 | - | $3.76 M(+33.0%) |
| Jun 2013 | - | $2.83 M(+8.6%) |
| Mar 2013 | - | $2.60 M(+29.4%) |
| Dec 2012 | $2.01 M(-46.8%) | $2.01 M(-8.2%) |
| Sep 2012 | - | $2.19 M(-19.2%) |
| Jun 2012 | - | $2.72 M(-27.4%) |
| Mar 2012 | - | $3.74 M(-1.1%) |
| Dec 2011 | $3.78 M(+64.2%) | $3.78 M(+175.4%) |
| Sep 2011 | - | $1.37 M(-18.5%) |
| Jun 2011 | - | $1.68 M(-15.5%) |
| Mar 2011 | - | $1.99 M(-13.5%) |
| Dec 2010 | $2.30 M(+1545.0%) | $2.30 M(+2299.0%) |
| Sep 2010 | - | $96.00 K(>+9900.0%) |
| Jun 2010 | - | $0.00(-100.0%) |
| Mar 2010 | - | $42.00 K(-70.0%) |
| Dec 2009 | $140.00 K(-93.5%) | $140.00 K(-35.8%) |
| Sep 2009 | - | $218.00 K(-75.5%) |
| Jun 2009 | - | $888.00 K(-49.7%) |
| Mar 2009 | - | $1.76 M(-17.7%) |
| Dec 2008 | $2.14 M(-57.3%) | $2.14 M(-31.3%) |
| Sep 2008 | - | $3.12 M(-19.3%) |
| Jun 2008 | - | $3.87 M(-13.2%) |
| Mar 2008 | - | $4.46 M(-11.3%) |
| Dec 2007 | $5.02 M(-24.6%) | $5.02 M(-5.6%) |
| Sep 2007 | - | $5.32 M(-11.9%) |
| Jun 2007 | - | $6.04 M(-1.2%) |
| Mar 2007 | - | $6.12 M(-8.2%) |
| Dec 2006 | $6.67 M | $6.67 M |
FAQ
- What is NovaBay Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual total long term liabilities year-on-year change?
- What is NovaBay Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly long term liabilities year-on-year change?
What is NovaBay Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of NBY is $1.44 M
What is the all time high annual total long term liabilities for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual total long term liabilities is $10.37 M
What is NovaBay Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, NBY annual total long term liabilities has changed by -$146.00 K (-9.19%)
What is NovaBay Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of NBY is $821.00 K
What is the all time high quarterly long term liabilities for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly total long term liabilities is $10.37 M
What is NovaBay Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, NBY quarterly total long term liabilities has changed by -$423.00 K (-34.00%)